<DOC>
	<DOCNO>NCT00368810</DOCNO>
	<brief_summary>This study examine whether resistance severe malaria associate weaken specific immune response ( TLR-mediated pro-inflammatory cytokine response ) . Some child mild malaria go develop severe disease , others . The study analyze certain substance blood try determine factor may protect severe malaria . Healthy child child 3 - 10 year age severe malaria treat l ' H pital Gabriel Toure Mamako , Mali , West Africa , may eligible study . Participants mall sample blood drawn vein two finger prick .</brief_summary>
	<brief_title>Study Factors Involved Resistance Severe Malaria</brief_title>
	<detailed_description>Malaria remain important public health threat , responsible two million death annually , majority among African child . The mechanisms underlying resistance severe manifestation malaria remain elusive . Severe malaria associate high level pro-inflammatory cytokine may contribute pathogenesis cerebral malaria , severe anemia acidosis . This response think drive primarily glycosylphosphatidylinositol ( GPI ) anchor derive erythrocyte-stage Plasmodium falciparum . It suggest antibody GPI responsible resistance severe malaria , lead effort develop GPI-based vaccine . An alternative explanation development resistance severe malaria regulation innate pro-inflammatory response repeat ligation toll-like receptor ( TLR ) GPI , putative P. falciparum-derived TLR ligand , hemozoin . This cross-sectional study l'Hopital Gabriel Toure Bamako , Mali , propose test hypothesis resistance severe malaria associate attenuation TLR-mediated pro-inflammatory cytokine response . After informed consent obtain participant 's parent guardian , 2-3 mL venous blood drawn 60 child : 40 child present acute P. falciparum infection ( 20 severe 20 uncomplicated ) 20 healthy , P. falciparum uninfected control . The blood test antibody titer GPI Merozoite Surface Protein-1 ( MSP-1 ) . Peripheral blood mononuclear cell ( PBMCs ) isolate cultured GPI , hemozoin , lipoteichoic acid ( LTA ) , lipopolysaccharide ( LPS ) , cytosine-guanine dinucleotide ( CpG ) . At 24 hour , supernatant collect follow cytokine measure : IL-1 , IL-6 , IL-8 , IL-10 , IL-12 , TNF-alpha . A clearer understand responsiveness TLR ligands child malaria endemic area may provide information potential intervention strategy GPI-based vaccine use TLR agonist vaccine adjuvant .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>INCLUSION CRITERIA MALARIA PATIENTS : 1 . Males female age 3 10 . 2 . Severe malaria define positive blood smear P. falciparum need hospitalization accordance WHO definition severe malaria ( group I ) , mild malaria define positive blood smear P. falciparum triage outpatient treatment ( group II ) . 3 . Willingness parent guardian child participate study evidence complete informed consent document . INCLUSION CRITERIA HEALTHY VOLUNTEERS : 1 . Males female age 3 10 . 2 . No clinical evidence malaria negative blood smear . 3 . No acute febrile systemic illness . 4 . Willingness parent guardian child participate study evidence complete informed consent document . EXCLUSION CRITERIAMALARIA PATIENTS : 1 . Active bleed hematocrit le equal 15 % . 2 . Participation vaccine drug trial within 30 day start study . 3 . Use corticosteroid immunosuppressive drug within 30 day start study . 4 . Receipt live vaccine within past 4 week kill vaccine within past 2 week prior entry study . 5 . Known history HIV infection . EXCLUSION CRITERIAHEALTHY VOLUNTEERS : 1 . Positive malaria smear . 2 . Sibling malaria patient . 3 . Active bleed hematocrit le equal 15 % . 4 . Participation vaccine drug trial within 30 day start study . 5 . Use corticosteroid immunosuppressive drug within 30 day start study . 6 . Receipt live vaccine within past 4 week kill vaccine within past 2 week prior entry study . 7 . Known history HIV infection .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>November 30, 2006</verification_date>
	<keyword>Children</keyword>
	<keyword>Cross-Sectional</keyword>
	<keyword>Glycosylphosphatidylinositol</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Peripheral Blood Mononuclear Cells</keyword>
	<keyword>Malaria</keyword>
</DOC>